XML 60 R52.htm IDEA: XBRL DOCUMENT v3.23.2
Investments - Narrative: Equity Method Investments (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Sep. 30, 2021
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Fair Value Measured at Net Asset Value Per Share | Limited Partnership            
Net Investment Income [Line Items]            
Alternative investments   $ 226   $ 226   $ 249
Unfunded additional commitments   157   157    
Net gains (losses) from limited partnership investments   $ (29) $ (60) $ (9) $ (220)  
Neumora Therapeutics, Inc.            
Net Investment Income [Line Items]            
Ownership percentage 25.90% 24.50%   24.50%   24.90%
Aggregate cost $ 257          
Cash payment 100          
Noncash consideration $ 157          
Fair value of investments   $ 316   $ 316   $ 335
Change in carrying value   $ 28 $ (39) $ (19) $ (89)